New Zealand markets open in 6 hours 10 minutes

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
127.89+0.39 (+0.31%)
As of 11:50AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close127.50
Open128.27
Bid127.79 x 900
Ask127.82 x 1100
Day's range127.09 - 128.73
52-week range99.14 - 133.10
Volume1,570,903
Avg. volume7,530,790
Market cap323.921B
Beta (5Y monthly)0.40
PE ratio (TTM)140.54
EPS (TTM)0.91
Earnings date30 Jul 2024
Forward dividend & yield3.08 (2.42%)
Ex-dividend date17 Jun 2024
1y target est142.98
  • Yahoo Finance Video

    FDA approves Merck's pneumonia vaccine for adults

    The Food and Drug Administration (FDA) has approved Merck's (MRK) new vaccine to protect adults from pneumonia. Yahoo Finance's Anjalee Khemlani reports more on how the vaccine works as the pharmaceutical company awaits the Centers for Disease Control's (CDC) recommendation. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl

  • Zacks

    Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval

    Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV specifically designed for adults to be approved by the FDA.

  • Simply Wall St.

    Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness

    In the last year, many Merck & Co., Inc. ( NYSE:MRK ) insiders sold a substantial stake in the company which may have...